Assessing the risk of concurrent mycoplasma pneumoniae pneumonia in children with tracheobronchial tuberculosis: retrospective study

被引:0
|
作者
Liu, Lin [1 ]
Jiang, Jie [1 ]
Wu, Lei [1 ]
Zeng, De miao [2 ]
Yan, Can [1 ]
Liang, Linlong [1 ]
Shi, Jiayun [1 ]
Xie, Qifang [1 ]
机构
[1] Univ South China, Affiliated Changsha Cent Hosp, Hengyang Med Sch, Dept Pediat, Changsha, Hunan, Peoples R China
[2] Kunming Med Univ, Southern Cent Hosp Yunnan Prov, Peoples Hosp Honghe State 1, Dept Joint Surg,HeHonghe Affiliated Hosp, Changsha, Hunan, Peoples R China
来源
PEERJ | 2024年 / 12卷
关键词
Machine learning; Extreme gradient boosting; Child; Tuberculosis; Tracheobronchial; Pneumonia; Mycoplasma;
D O I
10.7717/peerj.17164
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective: This study aimed to create a predictive model based on machine learning to identify the risk for tracheobronchial tuberculosis (TBTB) occurring alongside Mycoplasma pneumoniae pneumonia in pediatric patients. Methods: Clinical data from 212 pediatric patients were examined in this retrospective analysis. This cohort included 42 individuals diagnosed with TBTB and Mycoplasma pneumoniae pneumonia (combined group) and 170 patients diagnosed with lobar pneumonia alone (pneumonia group). Three predictive models, namely XGBoost, decision tree, and logistic regression, were constructed, and their performances were assessed using the receiver's operating characteristic (ROC) curve, precision-recall curve (PR), and decision curve analysis (DCA). The dataset was divided into a 7:3 ratio to test the first and second groups, utilizing them to validate the XGBoost model and to construct the nomogram model. Results: The XGBoost highlighted eight significant signatures, while the decision tree and logistic regression models identified six and five signatures, respectively. The ROC analysis revealed an area under the curve (AUC) of 0.996 for XGBoost, significantly outperforming the other models (p < 0.05). Similarly, the PR curve demonstrated the superior predictive capability of XGBoost. DCA further confirmed that XGBoost offered the highest AIC (43.226), the highest average net benefit (0.764), and the best model fit. Validation efforts confirmed the robustness of the findings, with the validation groups 1 and 2 showing ROC and PR curves with AUC of 0.997, indicating a high net benefit. The nomogram model was shown to possess significant clinical value. Conclusion: Compared to machine learning approaches, the XGBoost model demonstrated superior predictive efficacy in identifying pediatric patients at risk of concurrent TBTB and Mycoplasma pneumoniae pneumonia. The model's identification of critical signatures provides valuable insights into the pathogenesis of these conditions.
引用
收藏
页数:17
相关论文
共 50 条
  • [1] Analysis of the risk factors and clinical features of Mycoplasma pneumoniae pneumonia with embolism in children: a retrospective study
    Chunjiao Han
    Tongqiang Zhang
    Jiafeng Zheng
    Peng Jin
    Qi Zhang
    Wei Guo
    Yongsheng Xu
    Italian Journal of Pediatrics, 48
  • [2] Analysis of the risk factors and clinical features of Mycoplasma pneumoniae pneumonia with embolism in children: a retrospective study
    Han, Chunjiao
    Zhang, Tongqiang
    Zheng, Jiafeng
    Jin, Peng
    Zhang, Qi
    Guo, Wei
    Xu, Yongsheng
    ITALIAN JOURNAL OF PEDIATRICS, 2022, 48 (01)
  • [3] A retrospective study of azithromycin and ceftizoxime for the management of children with Mycoplasma pneumoniae pneumonia
    Han, Li-ping
    Xiao, Han-yan
    Fang, Li-li
    MEDICINE, 2021, 100 (44)
  • [4] Clinical Characteristics of Lung Consolidation with Mycoplasma pneumoniae Pneumonia and Risk Factors for Mycoplasma pneumoniae Necrotizing Pneumonia in Children
    Xue Zhang
    Ruiyang Sun
    Wanyu Jia
    Peng Li
    Chunlan Song
    Infectious Diseases and Therapy, 2024, 13 : 329 - 343
  • [5] Clinical Characteristics of Lung Consolidation with Mycoplasma pneumoniae Pneumonia and Risk Factors for Mycoplasma pneumoniae Necrotizing Pneumonia in Children
    Zhang, Xue
    Sun, Ruiyang
    Jia, Wanyu
    Li, Peng
    Song, Chunlan
    INFECTIOUS DISEASES AND THERAPY, 2024, 13 (02) : 329 - 343
  • [6] Risk Prediction Model for Necrotizing Pneumonia in Children with Mycoplasma pneumoniae Pneumonia
    Luo, Yonghan
    Wang, Yanchun
    JOURNAL OF INFLAMMATION RESEARCH, 2023, 16 : 2079 - 2087
  • [7] Risk factors for bronchiolitis obliterans development in children after Mycoplasma pneumoniae pneumonia: a retrospective study of 981 patients
    Xu, Weihan
    Wang, Heng
    Wen, Xiaohui
    Yang, Haiming
    Zhao, Shunying
    Liu, Jinrong
    ITALIAN JOURNAL OF PEDIATRICS, 2025, 51 (01)
  • [8] Predictive clinical indicators of refractory Mycoplasma pneumoniae pneumonia in children: A retrospective cohort study
    Pei, Hong
    Luo, Hongli
    MEDICINE, 2024, 103 (34)
  • [9] Monocyte subsets study in children with Mycoplasma pneumoniae pneumonia
    Zhihua Wang
    Lei Yang
    Jing Ye
    Yushui Wang
    Yan Liu
    Immunologic Research, 2019, 67 : 373 - 381
  • [10] Monocyte subsets study in children with Mycoplasma pneumoniae pneumonia
    Wang, Zhihua
    Yang, Lei
    Ye, Jing
    Wang, Yushui
    Liu, Yan
    IMMUNOLOGIC RESEARCH, 2019, 67 (4-5) : 373 - 381